# Amodiaquine Plus Artesunate Versus Lapdap Plus Artesunate in the Treatment of Uncomplicated P. Falciparum Malaria in Malawi

> **NCT00164359** · PHASE4 · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 212 (—)

## Conditions studied

- Malaria, Falciparum

## Interventions

- **DRUG:** Amodiaquine plus artesunate
- **DRUG:** chlorproguanil-dapsone plus artesunate

## Key facts

- **NCT ID:** NCT00164359
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2005-09
- **Final completion:** 2005-09
- **Target enrollment:** 212 (—)
- **Last updated:** 2012-09-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00164359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00164359, "Amodiaquine Plus Artesunate Versus Lapdap Plus Artesunate in the Treatment of Uncomplicated P. Falciparum Malaria in Malawi". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00164359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*